CKDinform Guide to CKD Detection and Delaying Progression

This document introduces the knowledge of the detection and delaying of chronic kidney disease, including GFR, ACR, the diagnosis and classification of CKD, as well as treatment methods.


CKDinform Guide to CKD Detection and Delaying Progression - cover page
Brand
CKDinform
Document type
User Manual
Language
English
Pages
14
File format
PDF
File size
184 KB
Published
20 October, 2023
Updated
20 October, 2023
MD5 checksum
216F5BCACA6C6FF6F54535492BF7E9D4

About this manual

This document serves as a guide for primary care physicians (PCPs) on the detection and management of Chronic Kidney Disease (CKD). It outlines evidence-based strategies for screening, utilizing tools such as GFR and ACR, and classifying CKD based on GFR and albuminuria categories to guide treatment approaches.

The guide details clinical evaluation methods, including blood pressure control, glycemic management, and the avoidance of nephrotoxic agents like NSAIDs. It also provides specific targets for blood pressure and albuminuria reduction to delay disease progression and improve patient outcomes, alongside recommendations for patient education and counseling.

What's inside

  • Classification of CKD
  • Clinical Evaluation
  • Blood Pressure and CKD Progression
  • Goals for Renoprotection
  • Managing Hyperglycemia
  • Other Goals of CKD Management
  • Complications of Kidney Failure
  • Education and Counseling

Frequently asked questions

What are the albuminuria categories and their corresponding ranges?

Albuminuria categories include A1 (normal to mildly increased), A2 (moderately increased), and A3 (severely increased).

What blood pressure targets are recommended for patients with ACR 30-300 mg/g?

The target blood pressure is ≤130/80 mm Hg for patients with ACR 30-300 mg/g.

What is the recommended sodium intake limit per day for CKD patients?

Limit sodium intake to <90 mmol (2 gm sodium) per day.

What is the target HbA1c for managing hyperglycemia in CKD patients?

The target HbA1c is ~7.0%.

Download PDF (184 KB)